# Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment

> **NCT04910256** · PHASE4 · COMPLETED · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 80 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Huatuo Zaizao Pills
- **OTHER:** Basic treatment

## Key facts

- **NCT ID:** NCT04910256
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-31
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-09-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04910256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04910256, "Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04910256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*